Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes
NCT02863172 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2026-04-17
Summary
Objectives:
1. To examine the variations in clinical features, survival outcomes, family history, and health behavior among proband patients who are known or suspected to have a hereditary colorectal cancer syndrome
2. To compare the clinical features, survival outcomes, and health behavior of the proband vs. his/her family members who may or may not be affected by the hereditary colorectal cancer syndrome
3. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in the overall disease phenotype across probands and kindreds, within a given syndrome. Disease phenotype is defined to include: (1) clinicopathologic features including patient demographics and oncologic outcomes; (2) clinical manifestations of disease including the timing, spectrum and severity of CRC and extracolonic cancers. Genetic variations may include the specific codon mutated, the type of mutation and sequence alteration (e.g. nonsense, missense etc), chromosomal/gene copy number changes, and gene polymorphisms.
4. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in somatic CRC tumor biology, including tumor pathology and other tumor molecular markers
Conditions
- Hereditary Colorectal Cancer Syndrome
Interventions
- BEHAVIORAL
-
Questionnaires
Consenting Proband Group: Participants fill out questionnaires about work, family history, medical history, and health habits at baseline. It should take about 20 minutes to complete the questionnaires. Participants also complete a health and lifestyle questionnaire, which contains 20 questions for men and 22 questions for women. Questionnaire should take about 10 minutes to complete. Follow-up questionnaire at least 1 time in 5 years to update medical, cancer, and family history. Family Members (MDA Registered Patients) Group and Family Members (Not MDA Registered Patients) Group: Participants complete a health questionnaire, which collects information about their personal medical history, demographics (age, race, sex, and so on), and questions about their alcohol and tobacco use at baseline. Questionnaire should take about 20 minutes to complete. Participants complete follow-up questionnaire at least 1 time in 5 years to update their medical, cancer, and family history.
- PROCEDURE
-
Blood Draw/Saliva Sample
About 2-3 tablespoons blood drawn. Participants may give a saliva sample instead.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Yi-Qian N. You, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-05-22
- Primary Completion
- 2027-05-30
- Completion
- 2027-05-30
Countries
- United States
Study Locations
More Related Trials
-
Genetic Markers in Patients With Colorectal Cancer
NCT00014079 ·Status: COMPLETED
-
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
NCT02371135 ·Status: ACTIVE_NOT_RECRUITING
-
Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
NCT00675636 ·Status: COMPLETED
-
Hereditary Colorectal and Associated Tumor Registry Study
NCT00633607 ·Status: COMPLETED
-
Implementation of Guidelines on Hereditary or Familial Colorectal Cancer
NCT00929097 ·Status: UNKNOWN ·Phase: NA
-
Colorectal Cancer Detected by 1H-NMR Spectroscopy
NCT02364154 ·Status: COMPLETED
-
Genetic Study of Patients and Families With a History of Colorectal Cancer
NCT00003648 ·Status: COMPLETED
-
Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression
NCT03309722 ·Status: UNKNOWN
-
Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer
NCT00516230 ·Status: UNKNOWN
-
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
NCT05410977 ·Status: RECRUITING
-
DNA Adductomics for Colorectal Cancer Investigation
NCT04865601 ·Status: RECRUITING
-
Presence of Circulating Tumor DNA in Colorectal Cancer
NCT01198743 ·Status: COMPLETED
-
Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in Taiwan
NCT00172757 ·Status: UNKNOWN
-
Validation of Advanced Colorectal Neoplasm Risk Categories in a Prospective Cohort in Mexico
NCT05661292 ·Status: UNKNOWN
-
Survivorship in Lynch Syndrome Families
NCT01126840 ·Status: COMPLETED
-
Prognostic Value of Circulating Tumoral Free DNA Versus Circulating Tumoral Cells in Patients With Colorectal Cancer Stage II-III
NCT02556281 ·Status: COMPLETED ·Phase: NA
-
Colorectal Cancer Screening Validation Study
NCT00720993 ·Status: UNKNOWN
-
Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer
NCT02217865 ·Status: COMPLETED
-
Screening for Familial Colorectal Cancer (CRC) Patients
NCT00632515 ·Status: COMPLETED
-
Screening With a DNA Blood Test to Address Colorectal Cancer Inequities
NCT06929481 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
NCT01260168 ·Status: COMPLETED
-
Systemic Screening for Hereditary Colorectal Cancer in China
NCT03365986 ·Status: UNKNOWN
-
Plasma-based Colorectal Cancer Screening Research & Development
NCT04027790 ·Status: COMPLETED
-
Identification of New Colorectal Cancer Genes
NCT00582335 ·Status: COMPLETED
-
Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
NCT05068531 ·Status: RECRUITING